Thank you for subscribing!
Next Investors Jul 04, 2023
Last month, a big pharma company swooped on two treatments for a rare kidney disease in a US$3.5BN deal. This $3.5BN deal sets a benchmark price by big pharma on later stage assets treating rare kidney diseases. It also highlights the M&A appetite for kidney drug development.
Next Investors Apr 01, 2023
This week we cover the extensive M&A foreground that is emerging during these current rough market conditions. Battery materials and energy companies that are in the partial development stage are particularly prevalent to becoming M&A targets during this market. Let's dive in...
Next Investors Mar 25, 2023
Global sentiment in the market remains low, with some great announcements being sold into and liquidity drying up in the small cap market. We cover some reasons for this phenomenon and look at why M&A activity seems to be rising in the emerging companies end of the market. Is this the perfect moment to be "greedy when others are fearful"?
Finfeed Archived Jun 24, 2021
Following much shareholder speculation, Bruce Linton, strategic advisor for Creso Pharma (ASX: CPH), spoke to The Dales Report to explain the reasoning behind the merger decision and the multitude of opportunities the merger uncovers.
Get expert stock analysis direct in your inbox
Next Investors Jun 17, 2021
Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.
Finfeed Archived Jun 01, 2021
A business update provided by Vonex Ltd (ASX: VN8) indicates that it continues to deliver strong growth assisted by acquisitions.
Finfeed Archived Jan 11, 2021
88 Energy Limited has acquired the previously producing Umiat Oil Field, which is in close proximity to Project Peregrine
Finfeed Archived Dec 18, 2020
Vonex Limited (ASX: VN8) has today announced its intention to acquire Nextel’s business and operations as a going concern. The acquisition will provide an immediate boost of approximately $1 million to Vonex’s base of annualised recurring revenue.
Finfeed Archived Nov 20, 2020
Sacgasco Ltd (ASX: SGC) has acquired a 30% working interest in the 1000 bopd Red Earth asset in Alberta, Canada.
Join Our Mailing List